Journal of Hepatology
Volume 53, Issue 2 , Pages 245-251 , August 2010

The natural history of hepatitis C infection acquired through injection drug use: Meta-analysis and meta-regression

  • Ava John-Baptiste

      Affiliations

    • Department of Health Policy, Management & Evaluation, University of Toronto, Canada
    • Toronto Health Economics and Technology Assessment Collaborative (THETA), University of Toronto, Canada
    • University Health Network, Toronto, Canada
    • Corresponding Author InformationCorresponding author at: Toronto Health Economics & Technology Assessment (THETA) Collaborative, University of Toronto, 144 College Street, 6th Floor, Room 658, Toronto, Canada M5S 3M2. Tel.: +1 416 946 3718; fax: +1 416 946 3719.
    • ,
  • Murray Krahn

      Affiliations

    • Department of Health Policy, Management & Evaluation, University of Toronto, Canada
    • Toronto Health Economics and Technology Assessment Collaborative (THETA), University of Toronto, Canada
    • Faculty of Pharmacy, University of Toronto, Canada
    • University Health Network, Toronto, Canada
    • ,
  • Jenny Heathcote

      Affiliations

    • University Health Network, Toronto, Canada
    • Department of Medicine, University of Toronto, Toronto, Canada
    • ,
  • Audery Laporte

      Affiliations

    • Department of Health Policy, Management & Evaluation, University of Toronto, Canada
    • Department of Medicine, University of Toronto, Toronto, Canada
    • ,
  • George Tomlinson

      Affiliations

    • Department of Health Policy, Management & Evaluation, University of Toronto, Canada
    • Toronto Health Economics and Technology Assessment Collaborative (THETA), University of Toronto, Canada
    • Dalla Lana School of Public Health, University of Toronto, Canada
    • University Health Network, Toronto, Canada

Received 14 December 2009 ,Revised 16 February 2010 ,Accepted 9 March 2010.

References 

  1. R Development Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2009;ISBN 3-900051-07-0. Available from: http://www.R-project.org
  2. Adeyemi OM, Jensen D, Attar B, Ghaoui R, Gallagher M, Wolen D, et al. Hepatitis C treatment eligibility in an urban population with and without HIV coinfection. AIDS Patient Care STDs. 2004;18:239–245
  3. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144:705–714[See comment: Summary for patients in Ann Intern Med 2006;144:I20; PMID: 16702583]
  4. Bacchetti P, Tien PC, Seaberg EC, O’Brien TR, Augenbraun MH, Kral AH, et al. Estimating past hepatitis C infection risk from reported risk factor histories: implications for imputing age of infection and modeling fibrosis progression. BMC Infect Dis. 2007;7:145
  5. Brau N, Salvatore M, Rios-Bedoya CF, Fernandez-Carbia A, Paronetto F, Rodriguez-Orengo JF, et al. Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy. J Hepatol. 2006;44:47–55
  6. Brooks SP, Gelman A. General methods for monitoring convergence of iterative simulations. J Comput Graph Stat. 1998;7:434–455
  7. Bruandet A, Lucidarme D, Decoster A, Ilef D, Harbonnier J, Jacob C, et al. Incidence and risk factors of HCV infection in a cohort of intravenous drug users in the North and East of France. Rev Epidemiol Sante Publique. 2006;54:1S15–11S22[in French]
  8. Cox DR. Analysis of survival data. New York: Chapman and Hall; 1984;
  9. Crofts N, Jolley D, Kaldor J, van Beek I, Wodak A. Epidemiology of hepatitis C virus infection among injecting drug users in Australia. J Epidemiol Commun Health. 1997;51:692–697
  10. De Groot MH. Optimal statistical decisions. New York: McGraw-Hill; 1970;
  11. DerSimonian R. Meta-analysis in the design and monitoring of clinical trials. Stat Med. 1996;15:1237–1248discussion 1249–1252
  12. Di Bisceglie AM. Hepatitis C. Lancet. 1998;351:351–355
  13. Di Bisceglie AM. Natural history of hepatitis C: its impact on clinical management. Hepatology. 2000;31:1014–1018
  14. Freeman AJ, Dore GJ, Law MG, Thorpe M, Von Overbeck J, Lloyd AR, et al. Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology. 2001;34:809–816
  15. Fu B, Tom BD, Delahooke T, Alexander GJ, Bird SM. Event-biased referral can distort estimation of hepatitis C virus progression rate to cirrhosis, and of prognostic influences. J Clin Epidemiol. 2007;60:1140–1148
  16. Grebely J, Raffa JD, Lai C, Krajden M, Kerr T, Fischer B, et al. Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents. J Viral Hepat. 2009;16:352–358
  17. Greenland S, Morgenstern H. Ecological bias, confounding, and effect modification. Int J Epidemiol. 1989;18:269–274
  18. John-Baptiste A, Varenbut M, Lingley M, Nedd-Roderique T, Teplin D, Tomlinson G, et al. Treatment of hepatitis C infection for current or former substance abusers in a community setting. J Viral Hepat. 2009;16:557–567
  19. Judd A, Hickman M, Jones S, McDonald T, Parry JV, Stimson GV, et al. Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study. BMJ. 2005;330:24–25
  20. Lambert PC, Sutton AJ, Abrams KR, Jones DR. A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis. J Clin Epidemiol. 2002;55:86–94
  21. Lunn DJ, Thomas A, Best N, Spiegelhalter D. WinBUGS – a Bayesian modelling framework: concepts, structure, and extensibility. Stat Comput. 2000;10:325–337
  22. Miller CL, Spittal PM, Frankish JC, Li K, Schechter MT, Wood E. HIV and hepatitis C outbreaks among high-risk youth in Vancouver demands a public health response. Can J Public Health. 2005;96:107–108
  23. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet. 1997;349:825–832
  24. Rodger AJ, Roberts S, Lanigan A, Bowden S, Brown T, Crofts N. Assessment of long-term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971 to 1975. Hepatology. 2000;32:582–587
  25. Schaefer M, Heinz A, Backmund M. Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules?. Addiction. 2004;99:1167–1175
  26. Shaheen AA, Myers RP. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review. Hepatology. 2007;46:912–921
  27. Smith AFM, Roberts GO. Bayesian computation via the Gibbs sampler and related Markov-chain Monte-Carlo methods. J R Stat Soc Ser B Methodol. 1993;55:3–23
  28. Spiegelhalter DJ, Myles JP, Jones DR, Abrams KR. Methods in health service research. An introduction to bayesian methods in health technology assessment. BMJ. 1999;319:508–512
  29. Strathdee SA, Patrick DM, Currie SL, Cornelisse PG, Rekart ML, Montaner JS, et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS. 1997;11:F59–F65
  30. Thein HH, Yi Q, Dore GJ, Krahn MD. Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression. Hepatology. 2008;48:418–431
  31. Thein HH, Yi Q, Dore GJ, Krahn MD. Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis. AIDS. 2008;22:1979–1991
  32. Thomas A, O’Hara B, Ligges U, Sturtz S. Making BUGS open. R News. 2006;6:12–17
  33. Villano SA, Vlahov D, Nelson KE, Lyles CM, Cohn S, Thomas DL. Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. J Clin Microbiol. 1997;35:3274–3277
  34. Yi Q, Wang PP, Krahn M. Improving the accuracy of long-term prognostic estimates in hepatitis C virus infection. J Viral Hepat. 2004;11:166–174

PII: S0168-8278(10)00386-7

doi: 10.1016/j.jhep.2010.03.015

Journal of Hepatology
Volume 53, Issue 2 , Pages 245-251 , August 2010

Article Tools

* Image Usage & Resolution